MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. [electronic resource]
Producer: 20180221Description: 83060-83070 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm -- genetics
- Gallbladder Neoplasms -- drug therapy
- Gene Expression Profiling -- methods
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Mice, Nude
- MicroRNAs -- genetics
- Neoplasm Invasiveness
- Oligonucleotide Array Sequence Analysis
- Proto-Oncogene Mas
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- RNA Interference
- Signal Transduction -- drug effects
- Time Factors
- Transfection
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
- bcl-2-Associated X Protein -- metabolism
- src-Family Kinases -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.